These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 15579496
21. mu-Opioid receptors desensitize less rapidly than delta-opioid receptors due to less efficient activation of arrestin. Lowe JD, Celver JP, Gurevich VV, Chavkin C. J Biol Chem; 2002 May 03; 277(18):15729-35. PubMed ID: 11861651 [Abstract] [Full Text] [Related]
22. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice. Kögel B, Christoph T, Strassburger W, Friderichs E. Eur J Pain; 2005 Oct 03; 9(5):599-611. PubMed ID: 16139189 [Abstract] [Full Text] [Related]
23. Refinement of a homology model of the mu-opioid receptor using distance constraints from intrinsic and engineered zinc-binding sites. Fowler CB, Pogozheva ID, LeVine H, Mosberg HI. Biochemistry; 2004 Jul 13; 43(27):8700-10. PubMed ID: 15236578 [Abstract] [Full Text] [Related]
24. Engineering and functional immobilization of opioid receptors. Ott D, Neldner Y, Cèbe R, Dodevski I, Plückthun A. Protein Eng Des Sel; 2005 Mar 13; 18(3):153-60. PubMed ID: 15790572 [Abstract] [Full Text] [Related]
25. Expression and biophysical analysis of two double-transmembrane domain-containing fragments from a yeast G protein-coupled receptor. Cohen LS, Arshava B, Estephan R, Englander J, Kim H, Hauser M, Zerbe O, Ceruso M, Becker JM, Naider F. Biopolymers; 2008 Mar 13; 90(2):117-30. PubMed ID: 18260136 [Abstract] [Full Text] [Related]
26. Acute and chronic fentanyl administration causes hyperalgesia independently of opioid receptor activity in mice. Waxman AR, Arout C, Caldwell M, Dahan A, Kest B. Neurosci Lett; 2009 Oct 02; 462(1):68-72. PubMed ID: 19559072 [Abstract] [Full Text] [Related]
27. Mu and delta opioid receptors are differentially desensitized by the coexpression of beta-adrenergic receptor kinase 2 and beta-arrestin 2 in xenopus oocytes. Kovoor A, Nappey V, Kieffer BL, Chavkin C. J Biol Chem; 1997 Oct 31; 272(44):27605-11. PubMed ID: 9346897 [Abstract] [Full Text] [Related]
28. Conserved polar residues in the transmembrane domain of the human tachykinin NK2 receptor: functional roles and structural implications. Donnelly D, Maudsley S, Gent JP, Moser RN, Hurrell CR, Findlay JB. Biochem J; 1999 Apr 01; 339 ( Pt 1)(Pt 1):55-61. PubMed ID: 10085227 [Abstract] [Full Text] [Related]
29. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes. Lester PA, Traynor JR. Brain Res; 2006 Feb 16; 1073-1074():290-6. PubMed ID: 16443205 [Abstract] [Full Text] [Related]
30. Opioid-induced regulation of gene expression in PC12 cells stably transfected with mu-opioid receptor. Zarnegar P, Persson AI, Ming Y, Terenius L. Neurosci Lett; 2006 Apr 03; 396(3):197-201. PubMed ID: 16377088 [Abstract] [Full Text] [Related]
31. Diverse immunocytochemical expression of opioid receptors in electrophysiologically defined cells of rat dorsal root ganglia. Rau KK, Caudle RM, Cooper BY, Johnson RD. J Chem Neuroanat; 2005 Jun 03; 29(4):255-64. PubMed ID: 15927787 [Abstract] [Full Text] [Related]
32. Genioglossal hypoglossal muscle motoneurons are contacted by nerve terminals containing delta opioid receptor but not mu opioid receptor-like immunoreactivity in the cat: a dual labeling electron microscopic study. Richardson KA, Gatti PJ. Brain Res; 2005 Jan 25; 1032(1-2):23-9. PubMed ID: 15680937 [Abstract] [Full Text] [Related]
33. Opposite alterations of NPFF1 and NPFF2 neuropeptide FF receptor density in the triple MOR/DOR/KOR-opioid receptor knockout mouse brains. Gouardères C, Kieffer BL, Zajac JM. J Chem Neuroanat; 2004 May 25; 27(2):119-28. PubMed ID: 15121216 [Abstract] [Full Text] [Related]
34. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles. Ioja E, Tourwé D, Kertész I, Tóth G, Borsodi A, Benyhe S. Brain Res Bull; 2007 Sep 14; 74(1-3):119-29. PubMed ID: 17683797 [Abstract] [Full Text] [Related]
35. Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor. Nachtergael I, Gaspard N, Langlet C, Robberecht P, Langer I. Cell Signal; 2006 Dec 14; 18(12):2121-30. PubMed ID: 16650965 [Abstract] [Full Text] [Related]
36. Rescuing the traffic-deficient mutants of rat mu-opioid receptors with hydrophobic ligands. Chaipatikul V, Erickson-Herbrandson LJ, Loh HH, Law PY. Mol Pharmacol; 2003 Jul 14; 64(1):32-41. PubMed ID: 12815158 [Abstract] [Full Text] [Related]
37. Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance. Zhao M, Joo DT. Anesthesiology; 2008 Aug 14; 109(2):308-17. PubMed ID: 18648240 [Abstract] [Full Text] [Related]
38. Role of the extracellular amino terminus and first membrane-spanning helix of dopamine D1 and D5 receptors in shaping ligand selectivity and efficacy. D'Aoust JP, Tiberi M. Cell Signal; 2010 Jan 14; 22(1):106-16. PubMed ID: 19786093 [Abstract] [Full Text] [Related]
39. Agonist-specific down regulation of mu-opioid receptors: Different cellular pathways are activated by different opioid agonists. Binyaminy B, Gafni M, Shapira M, Sarne Y. Life Sci; 2008 Apr 09; 82(15-16):831-9. PubMed ID: 18358497 [Abstract] [Full Text] [Related]
40. mu-Opioid agonists inhibit the enhanced intracellular Ca(2+) responses in inflammatory activated astrocytes co-cultured with brain endothelial cells. Hansson E, Westerlund A, Björklund U, Olsson T. Neuroscience; 2008 Sep 09; 155(4):1237-49. PubMed ID: 18692967 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]